Search

everythinglearnresearchcommunity

for

Search:↓

Certain plant extracts can effectively treat skin conditions like athlete's foot, chronic vein problems, sun damage, skin growths, vitiligo, and hair loss, and may also improve skin appearance.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

Daily low-dose aspirin lowers minoxidil's effectiveness for hair loss treatment.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

Clascoterone may be a promising treatment for hair loss.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Topical booster improves hair loss treatment effectiveness.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Lipase H is important for hair follicle function and shaping hair fibers.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

The editorial concludes that while evidence-based medicine is crucial, doctors should also use their own experience and consider patient preferences in dermatology care.

Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.

Robotic-assisted hair transplant is effective and less painful, but needs more evaluation for long-term results.

Reflectance confocal microscopy can noninvasively diagnose onychomatricoma by showing unique features different from healthy nails or nail fungus.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.